Antonio López Pousa, MD

Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain

Disclosure information not submitted.

Presentation(s):

• Paper 105 - EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE MOTION PHASE 3 TRIAL

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST